Skip to content
buyNotable cluster of 5

Fairmount Funds Management LLC bought $6.0M of ZBIO

director at Zenas BioPharma, Inc.. 316,219 shares at an average of $19.00, traded Oct 7, 2025, filed Oct 9, 2025.

Conviction score
62
Value
$6.0M
316,219 shares
Holdings after
2,209,025
+17% from before
From 52-week low
+224%
low $6.43, close $20.85
From 52-week high
-19%
high $25.68, as of Oct 7, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $6.0M at market
    +25
  • Relative to holdings
    Holdings up 17%
    +3
  • Price context
    19% below the 52-week high
    +4
  • Cluster
    5 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +21.1%, 3m -40.9%, 6m -23.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ZBIOOct 12, 2026 · close 26.40
Since filing Oct 9, 2025: -4.9%SPY +17.2% · excess -22.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-25-098362, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 7, 2025POpen-market purchase
Common Stockindirect: By Fairmount Healthcare Fund II L.P.
+316,219$19.00$6.0M2,209,025Oct 9, 2025

Related signals

Other insiders at Zenas BioPharma, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
78Notable
ZBIObuy
Zenas BioPharma, Inc.
Leon O Moulder Jr
Chief Executive Officer
$1.0M
60,000 shares
+162%
63Notable
ZBIObuy
Zenas BioPharma, Inc.
Leon O Moulder Jr
Chief Executive Officer
$1.1M
60,000 shares
+3%
46Moderate
ZBIObuy 3
Zenas BioPharma, Inc.
Hongbo Lu
director
$70k
3,768 shares
+1%
66Notable
ZBIObuy 3
Zenas BioPharma, Inc.
Fairmount Funds Management LLC
director
$3.0M
150,000 shares
+7%
74Notable
ZBIObuy 3
Zenas BioPharma, Inc.
Hongbo Lu
director
$1.5M
75,000 shares
+22%
78Notable
ZBIObuy 3
Zenas BioPharma, Inc.
Leon O Moulder Jr
Chief Executive Officer
$1.0M
54,000 shares
+3%
64Notable
ZBIObuy 3
Zenas BioPharma, Inc.
Patricia L Allen
director
$500k
19,860 shares
-
60Notable
ZBIObuy 3
Zenas BioPharma, Inc.
Hongbo Lu
director
$585k
25,985 shares
+8%
81Strong
ZBIObuy 3
Zenas BioPharma, Inc.
Leon O Moulder Jr
Chief Executive Officer
$1.0M
57,000 shares
+16%
64Notable
ZBIObuy
Zenas BioPharma, Inc.
Leon O Moulder Jr
Chief Executive Officer
$1.6M
100,000 shares
+38%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Fairmount Funds Management LLC bought $6.0M of ZBIO | InsiderTell